Your browser doesn't support javascript.
loading
Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies.
Rodrigo, C; Weeratunga, P; Fernando, S D; Rajapakse, S.
Affiliation
  • Rodrigo C; Department of Pathology, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia. Electronic address: c.rodrigo@unsw.edu.au.
  • Weeratunga P; Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Sri Lanka.
  • Fernando SD; Department of Parasitology, Faculty of Medicine, University of Colombo, Sri Lanka.
  • Rajapakse S; Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Sri Lanka.
Clin Microbiol Infect ; 24(6): 591-598, 2018 Jun.
Article in En | MEDLINE | ID: mdl-29138100

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amphotericin B / Leishmaniasis, Visceral / Antiprotozoal Agents Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Male Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2018 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amphotericin B / Leishmaniasis, Visceral / Antiprotozoal Agents Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Male Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2018 Document type: Article Country of publication: United kingdom